Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertensionheart failure and percutenous coronary interventions (PCI).

News | Pulmonary Embolism

May 11, 2018 — Results of the FlowTriever Pulmonary Embolectomy (FLARE) study were presented as late-breaking clinical ...

Home May 11, 2018
Home
News

 


May 11, 2018 — Two studies examining seasonal variations in cardiac-related hospitalizations, specifically for ...

Home May 11, 2018
Home
News | Structural Heart

May 11, 2018 — The post-approval study evaluating the safety and efficacy of MitraClip in a real-world, commercial ...

Home May 11, 2018
Home
News | Vascular Closure Devices

May 10, 2018 — Cardiva Medical Inc. announced the completion of the AMBULATE pivotal trial, one of several clinical ...

Home May 10, 2018
Home
News | Radiation Dose Management

May 10, 2018 — A new consensus document has been issued to guide the optimal use of ionizing radiation in cardiovascular ...

Home May 10, 2018
Home
Blog | Radiation Dose Management

In the past, there was not much that could be done to mitigate the X-ray radiation exposure of interventional ...

Home May 10, 2018
Home
Technology | Radiation Dose Management

We started our design from the ground up, tested many prototypes, did not want to compromise on radiation protection for ...

Home May 10, 2018
Home
Technology | Cardiovascular Information Systems (CVIS)

May 9, 2018 — Infinitt North America announced that Infinitt Cardiology Suite-v 1.0.8.1 has achieved certification from ...

Home May 09, 2018
Home
Technology | Implantable Cardiac Monitor (ICM)

 May 9, 2018 — The U.S. Food and Drug Administration (FDA) said it recently granted market clearance for Angel Medical ...

Home May 09, 2018
Home
Technology

May 8, 2018 — Biosense Webster Inc. announced its Carto Vizigo Bi-directional Guiding Sheath is now available in the ...

Home May 08, 2018
Home
News | Embolic Protection Devices

May 8, 2018 — One-year results from the Sentinel Cerebral Protection System show it can reduce the incidence of stroke d ...

Home May 08, 2018
Home
Recent Acquisitions Eroding Prices in Billion Dollar European Interventional Cardiology cath lab Market.
Feature | Cath Lab | Simon Trinh and Jeffrey Wong

The European interventional cardiology market is currently valued at nearly $1.4 billion. This is a mature market that ...

Home May 07, 2018
Home
Videos | Cath Lab

Imran Ahmad, M.D., medical director of interventional cardiology, explains some of the new technologies his labs have ...

Home May 07, 2018
Home
The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first antidote indicated for patients treated with rivaroxaban (Xarelto) and apixaban (Eliquis), when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.
Feature | Antiplatelet and Anticoagulation Therapies

May 7, 2018 — The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first ...

Home May 07, 2018
Home
An 3D echo view of a Neovasc Tiara transcatheter mitral valve. This valve is currently in clinical trials and is ahead of most of the TMVR devices in development.
Feature | Heart Valve Technology | Dave Fornell, Editor

May 4, 2018 — Transcatheter valve technology has been advancing very quickly and the links to aggregated content from ...

Home May 04, 2018
Home
Subscribe Now